• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者的晚期死亡率:一项基于人群的澳大利亚研究。

Late mortality in people with cancer: a population-based Australian study.

机构信息

Flinders Medical Centre, Adelaide, SA.

Flinders University, Adelaide, SA.

出版信息

Med J Aust. 2021 Apr;214(7):318-323. doi: 10.5694/mja2.50879. Epub 2020 Dec 9.

DOI:10.5694/mja2.50879
PMID:33296507
Abstract

OBJECTIVES

To investigate causes of death of people with cancer alive five years after diagnosis, and to compare mortality rates for this group with those of the general population.

DESIGN, SETTING, PARTICIPANTS: Retrospective cohort study; analysis of South Australian Cancer Registry data for all people diagnosed with cancer during 1990-1999 and alive five years after diagnosis, with follow-up to 31 December 2016.

MAIN OUTCOME MEASURES

All-cause and cancer cause-specific mortality, by cancer diagnosis; standardised mortality ratios (study group v SA general population) by sex, age at diagnosis, follow-up period, and index cancer.

RESULTS

Of 32 646 people with cancer alive five years after diagnosis, 30 309 were of European background (93%) and 16 400 were males (50%); the mean age at diagnosis was 60.3 years (SD, 15.7 years). The median follow-up time was 17 years (IQR, 11-21 years); 17 268 deaths were recorded (53% of patients; mean age, 80.6 years; SD, 11.4 years): 7845 attributed to cancer (45% of deaths) and 9423 attributed to non-cancer causes (55%). Ischaemic heart disease was the leading cause of death (2393 deaths), followed by prostate cancer (1424), cerebrovascular disease (1175), and breast cancer (1118). The overall standardised mortality ratio (adjusted for age, sex, and year of diagnosis) was 1.24 (95% CI, 1.22-1.25). The cumulative number of cardiovascular deaths exceeded that of cancer cause-specific deaths from 13 years after cancer diagnosis.

CONCLUSIONS

Mortality among people with cancer who are alive at least five years after diagnosis was higher than for the general population, particularly cardiovascular disease-related mortality. Survivorship care should include early recognition and management of risk factors for cardiovascular disease.

摘要

目的

调查诊断后五年仍存活的癌症患者的死亡原因,并比较该人群的死亡率与普通人群的死亡率。

设计、地点和参与者:回顾性队列研究;对 1990 年至 1999 年期间被诊断患有癌症且诊断后五年仍存活的所有患者的南澳大利亚癌症登记处数据进行分析,随访至 2016 年 12 月 31 日。

主要结局测量指标

所有原因和癌症特异性死因,按癌症诊断分类;按性别、诊断时年龄、随访期和索引癌症划分的标准化死亡率比(研究组与南澳大利亚普通人群)。

结果

在诊断后五年仍存活的 32646 名癌症患者中,30309 人(93%)为欧洲背景,16400 人(50%)为男性;诊断时的平均年龄为 60.3 岁(标准差,15.7 岁)。中位随访时间为 17 年(IQR,11-21 年);共记录了 17268 例死亡(53%的患者;平均年龄为 80.6 岁;标准差,11.4 岁):7845 例归因于癌症(死亡的 45%),9423 例归因于非癌症原因(55%)。缺血性心脏病是主要死因(2393 例死亡),其次是前列腺癌(1424 例)、脑血管病(1175 例)和乳腺癌(1118 例)。总体标准化死亡率(按年龄、性别和诊断年份调整)为 1.24(95%CI,1.22-1.25)。从癌症诊断后 13 年开始,心血管疾病死亡人数超过癌症特异性死亡人数。

结论

诊断后至少存活五年的癌症患者的死亡率高于普通人群,特别是心血管疾病相关死亡率。生存护理应包括早期识别和管理心血管疾病的危险因素。

相似文献

1
Late mortality in people with cancer: a population-based Australian study.癌症患者的晚期死亡率:一项基于人群的澳大利亚研究。
Med J Aust. 2021 Apr;214(7):318-323. doi: 10.5694/mja2.50879. Epub 2020 Dec 9.
2
A population-based study of cardiovascular disease mortality risk in US cancer patients.基于人群的美国癌症患者心血管疾病死亡风险研究。
Eur Heart J. 2019 Dec 21;40(48):3889-3897. doi: 10.1093/eurheartj/ehz766.
3
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.基于人群的早期乳腺癌患者心血管死亡率研究。
JAMA Cardiol. 2017 Jan 1;2(1):88-93. doi: 10.1001/jamacardio.2016.3841.
4
Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.甲状腺功能亢进、甲状腺功能减退与特定病因死亡率:一项大型女性队列研究
Thyroid. 2017 Aug;27(8):1001-1010. doi: 10.1089/thy.2017.0063. Epub 2017 Jul 6.
5
Noncancer deaths in white adult cancer patients.成年白人癌症患者的非癌症死亡情况。
J Natl Cancer Inst. 1993 Jun 16;85(12):979-87. doi: 10.1093/jnci/85.12.979.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.来自五大洲 21 个国家的中年成年人常见疾病、住院和死亡的变化(PURE):一项前瞻性队列研究。
Lancet. 2020 Mar 7;395(10226):785-794. doi: 10.1016/S0140-6736(19)32007-0. Epub 2019 Sep 3.
8
Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study.2001-2016 年香港糖尿病患者全因死亡率和死因特异性死亡率的变化趋势:一项回顾性队列研究。
Diabetologia. 2020 Apr;63(4):757-766. doi: 10.1007/s00125-019-05074-7. Epub 2020 Jan 16.
9
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study.2006 年至 2015 年澳大利亚人群癌症患者的心血管疾病和其他竞争死亡原因:一项基于人群的研究。
Cancer. 2019 Feb 1;125(3):442-452. doi: 10.1002/cncr.31806. Epub 2018 Oct 12.
10
Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016.2000 年至 2016 年美国转移性前列腺癌患者的死因。
JAMA Netw Open. 2021 Aug 2;4(8):e2119568. doi: 10.1001/jamanetworkopen.2021.19568.

引用本文的文献

1
Patterns of medication use following breast cancer diagnosis: an Australian population-based study.乳腺癌诊断后的用药模式:一项基于澳大利亚人群的研究。
Support Care Cancer. 2025 Jul 8;33(8):668. doi: 10.1007/s00520-025-09732-y.
2
Breast and prostate cancer survivors' understanding of risk and management of cardiovascular and musculoskeletal side effects of treatment: findings from focus groups.乳腺癌和前列腺癌幸存者对治疗相关心血管及肌肉骨骼副作用风险与管理的理解:焦点小组研究结果
Support Care Cancer. 2025 Jun 21;33(7):608. doi: 10.1007/s00520-025-09642-z.
3
A Comprehensive Review of Radiotherapy-Induced Coronary Artery Disease-Epidemiology, Biological Mechanisms, and Preventive Strategies.
放射治疗诱发冠状动脉疾病的综合综述——流行病学、生物学机制及预防策略
Int J Mol Sci. 2025 Jun 4;26(11):5401. doi: 10.3390/ijms26115401.
4
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population-Based Cohort Study.癌症患者的心血管药物使用与医疗服务利用:一项基于人群的回顾性队列研究。
Cancer Med. 2025 May;14(9):e70911. doi: 10.1002/cam4.70911.
5
Application of deep learning in automated localization and interpretation of coronary artery calcification in oncological PET/CT scans.深度学习在肿瘤学PET/CT扫描中冠状动脉钙化的自动定位与解读中的应用。
Int J Cardiovasc Imaging. 2025 Mar;41(3):453-465. doi: 10.1007/s10554-025-03327-8. Epub 2025 Jan 13.
6
Association of cardiovascular disease on cancer: observational and mendelian randomization analyses.心血管疾病与癌症的关联:观察性和孟德尔随机化分析
Sci Rep. 2024 Dec 24;14(1):28465. doi: 10.1038/s41598-024-78787-4.
7
Text message intervention delivered from Australian general practices to improve breast cancer survivors' physical activity and cardiovascular risk factors: protocol for the EMPOWER-SMS-GP effectiveness implementation randomised controlled trial.澳大利亚全科医疗提供的短信干预以改善乳腺癌幸存者的身体活动和心血管危险因素:EMPOWER-SMS-GP有效性实施随机对照试验方案
BMJ Open. 2024 Dec 11;14(12):e090984. doi: 10.1136/bmjopen-2024-090984.
8
Cardiac events among a cohort of 17,389 patients receiving cancer chemotherapy: short and long term implications.17389名接受癌症化疗患者队列中的心脏事件:短期和长期影响
Cardiooncology. 2024 Oct 16;10(1):72. doi: 10.1186/s40959-024-00269-3.
9
Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta-analysis.癌症患者与普通人群的心血管死亡率比较:系统评价和荟萃分析。
Cancer Med. 2024 Aug;13(15):e70057. doi: 10.1002/cam4.70057.
10
Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers.21种非转移性癌症患者的长期和短期心血管疾病死亡率
J Adv Res. 2025 Mar;69:215-224. doi: 10.1016/j.jare.2024.03.017. Epub 2024 Mar 26.